These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 3063747)
1. Lofepramine and psychomotor function. Hindmarch I Int Clin Psychopharmacol; 1988 Nov; 3 Suppl 2():71-7. PubMed ID: 3063747 [No Abstract] [Full Text] [Related]
2. Does lofepramine have fewer side effects than amitriptyline? Results of a comparative trial. Pugh R; Bell J; Cooper AJ; Dunstan S; Greedharry D; Pomeroy J; Raptopoulos P; Rowsell C; Steinert J; Priest RG J Affect Disord; 1982 Dec; 4(4):355-63. PubMed ID: 6219149 [TBL] [Abstract][Full Text] [Related]
3. Improvement of depression with lofepramine (Gamanil). A multicentre hospital assessment of a new antidepressant. Morse PF; Smith TG Br J Clin Pract; 1984 Sep; 38(9):301-5. PubMed ID: 6477810 [No Abstract] [Full Text] [Related]
7. Lofepramine in clinical practice. Peet M Int Clin Psychopharmacol; 1988 Nov; 3 Suppl 2():39-48. PubMed ID: 3063743 [No Abstract] [Full Text] [Related]
8. Lofepramine in the elderly. Pitt BM Int Clin Psychopharmacol; 1988 Nov; 3 Suppl 2():49-54. PubMed ID: 3063744 [TBL] [Abstract][Full Text] [Related]
9. Advances in the chemotherapy of depression: lofepramine. Proceedings of a symposium. London, 16th February 1988. Int Clin Psychopharmacol; 1988 Nov; 3 Suppl 2():1-77. PubMed ID: 3216097 [No Abstract] [Full Text] [Related]
10. A double blind comparison of lofepramine, imipramine and placebo in patients with depression. Feighner JP; Meridith CH; Dutt JE; Hendrickson GG Acta Psychiatr Scand; 1982 Aug; 66(2):100-8. PubMed ID: 6753500 [TBL] [Abstract][Full Text] [Related]
11. A double-blind comparison of the pharmacodynamic effects of single doses of lofepramine, amitriptyline and placebo in elderly subjects. Ghose K; Sedman E Eur J Clin Pharmacol; 1987; 33(5):505-9. PubMed ID: 3428344 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of the therapeutic effects of lofepramine and maprotiline in depression]. Finke G; Wegener G MMW Munch Med Wochenschr; 1982 Mar; 124(12):301-3. PubMed ID: 6804813 [No Abstract] [Full Text] [Related]
13. Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Lancaster SG; Gonzalez JP Drugs; 1989 Feb; 37(2):123-40. PubMed ID: 2649353 [TBL] [Abstract][Full Text] [Related]
14. Lofepramine versus dothiepin in the treatment of depression in elderly patients. Fairbairn AF; George K; Dorman T Br J Clin Pract; 1989 Feb; 43(2):55-60. PubMed ID: 2679835 [No Abstract] [Full Text] [Related]
15. A double-blind comparison of lofepramine and clomipramine in depressed outpatients. Dimitriou E; Paraschos A; Logothetis J Psychopharmacol Bull; 1984; 20(4):684-7. PubMed ID: 6387760 [No Abstract] [Full Text] [Related]
16. Lofepramine: a return to tricyclic antidepressives. Drug Ther Bull; 1983 Dec; 21(25):99-100. PubMed ID: 6662044 [No Abstract] [Full Text] [Related]
19. A prospective evaluation of the hepatotoxicity of lofepramine in the elderly. Kelly C; Roche S; Naguib M; Webb S; Roberts M; Pitt B Int Clin Psychopharmacol; 1993; 8(2):83-6. PubMed ID: 8102151 [TBL] [Abstract][Full Text] [Related]